{"a":[{"_":"Boehringer Ingelheim again rises up rare disease reputation rankings","$":{"href":"/marketing/boehringer-ingelheim-again-rises-rare-disease-reputation-rankings","hreflang":"en"}}]}

Summary

Boehringer Ingelheim improved its standing in patient groups' rare disease company rankings, continuing gains from the previous year, though it remained outside the top three companies on the overall leaderboard.